You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (10) |
Back to Search
Effect of Obesity on the Transdermal Absorption of Fentanyl
- In: Poster Presentation
- At: Stockholm (Sweden) (2017)
- Type: Poster
- Poster code: P-A-099-Monday
- By: SAI, Yoshimichi (Kanazawa University, Department of Hospital Pharmacy, Kanazawa, Japan)
- Co-author(s): Yoshimichi Sai: Department of Hospital Pharmacy, Kanazawa University, Kanazawa, Japan
Shintaro Gake: School of Pharmacy, Kanazawa University, Kanazawa, Japan
Makiko Takabayashi: Department of Hospital Pharmacy, Kanazawa University, Kanazawa, Japan
Hiroko Sanada: School of Pharmacy, Kanazawa University, Kanazawa, Japan
Yuriko Yoda: Department of Hospital Pharmacy, Kanazawa University, Kanazawa, Japan
Eriko Yasuda: Department of Hospital Pharmacy, Kanazawa University, Kanazawa, Japan
Yusuke Hara: Department of Hospital Pharmacy, Kanazawa University, Kanazawa, Japan
Tsutomu Shimada: Department of Hospital Pharmacy, Kanazawa University, Kanazawa, Japan
Ken-Ichi Miyamoto: Department of Hospital Pharmacy, Kanazawa University, Kanazawa, Japan - Abstract:
Backgrounds
Fentanyl, a synthetic µ1-opioid subjected to significant metabolism by CYP3A, is clinically approved as transdermal patch. The dose should be titrated individually to a tolerable and adequate analgesia. But its intra-individual variation of the transdermal absorption has not been clarified yet.Aims
We aimed to clarify effect of obesity.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026